Industries > Pharma > Antifungal Drug Market Report to 2031
Antifungal Drug Market Report to 2031
By Type (Azoles, Echinocandins, Polyenes), by Application (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Administration (Drugs, Powders, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Global Antifungal Drugs Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Antifungal Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Global Antifungal Drugs report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antifungal Drugs Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.
Antifungal Drugs Market by Type
• Azoles
• Echinocandins
• Polyenes
Antifungal Drugs Market by Application
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Others
Antifungal Drugs Market by Administration
• Drugs
• Powders
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Japan
o Rest of Asia Pacific
• Latin America
o Rest of Latin America
• Middle East and Africa
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Antifungal Drugs Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Global Antifungal Drugs Market with forecasts by type, by application and by administration type each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Antifungal Drugs Market report helps you
In summary, our 260+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Antifungal Drugs Market, with forecasts by type, by application, and by administration each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Antifungal Drugs market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Antifungal Drugs of the major companies involved in the Antifungal Drugs Market. Some of the company’s profiled in this report include-
• Pfizer Inc.
• GlaxoSmithKline Plc
• Bayer Healthcare LLC
• Novartis AG
• Sanofi-Aventis
• Merck & Co.,
• Glenmark Pharmaceuticals Ltd.
• Basilea Pharmaceutica Ltd.
• SCYNEXIS Inc.
• F2G Ltd
• Cipla Health
• Kramer Laboratories,
• Enzon Pharmaceuticals
• Gilead Science Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
With Information found nowhere else
our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the global Antifungal Drugs Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Antifungal Drugs Market Report to 2031: By Type (Azoles, Echinocandins, Polyenes), by Application (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Administration (Drugs, Powders, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Antifungal Drugs Market
2.1. Antifungal Drugs Market Definition
2.2. By Type Submarkets Definitions
2.3. By Application Submarkets Definitions
2.4. By Administration Submarkets Definitions
3. Antifungal Drugs Market Overview
3.1. Global Antifungal Drugs Market Size and Forecast by Region
3.2. Global Antifungal Drugs Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Incidences of Fungal Infection.
3.3.1.2. Increasing Awareness to Treat Infection Among People.
3.3.1.3. Invasive Procedures at Hospitals Increases Risk of Fungal Infections.
3.3.2. Market Restraints/Challenges
3.3.2.1. Emerging Antifungal Resistance in Drugs.
3.3.2.2. Availability of Limited Number of Antifungal Drugs to Treat Fungal Infection.
3.3.3. Opportunities
3.3.3.1. Ongoing R&D for Developing Advanced Antifungal Drugs
3.3.3.2. Increasing Demand for Antifungal Drugs as Over the Counter (OTC) Drugs.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Antifungal Drugs Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Azoles
4.1.2. Echinocandins
4.1.3. Polyenes
5. Global Antifungal Drugs Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Aspergillosis
5.1.2. Rising Patients with the Weak Immune System or Lung Disease
5.1.3. Dermatophytosis
5.1.4. Dermatophytosis is an Infection of Skin, Hair, Or Nails Caused by Dermatophyte.
5.1.5. Candidiasis
5.1.6. Candida Albicans is the Most Common Fungal Infection, Which Normally Lives on the Skin and Inside the Body.
5.1.7. Others
6. Global Antifungal Drugs Market Analysis and Forecast, 2021-2031 By Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Drugs
6.1.2. Powders
6.1.3. Others
7. North America Antifungal Drugs Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Antifungal Drugs Market Size and Forecast by Type
7.3. North America Antifungal Drugs Market Size and Forecast by Application
7.4. North America Antifungal Drugs Market Size and Forecast by Administration
7.5. U.S. Antifungal Drugs Market
7.5.1. Increasing Cases of Candidemia
7.6. Canada Antifungal Drugs Market
7.6.1. Increasing Awareness for Fungal Infection
8. Europe Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Antifungal Drugs Market Size and Forecast by Type
8.3. Europe Antifungal Drugs Market Size and Forecast by Application
8.4. Europe Antifungal Drugs Market Size and Forecast by Administration
8.5. UK Antifungal Drugs Market
8.6. Germany Antifungal Drugs Market
8.7. France Antifungal Drugs Market
8.8. Rest of Europe Antifungal Drugs Market
9. Asia Pacific Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Antifungal Drugs Market Size and Forecast by Type
9.3. Asia Pacific Antifungal Drugs Market Size and Forecast by Application
9.4. Asia Pacific Antifungal Drugs Market Size and Forecast by Administration
9.5. China Antifungal Drugs Market
9.5.1. Increasing Prevalence of Fungal Infection Among Elderly.
9.6. India Antifungal Drugs Market
9.6.1. Increasing Number of Fungal Infections in the Region.
9.7. Japan Antifungal Drugs Market
9.7.1. Growing Use of Antifungals Such as Echinocandin
9.8. Rest of Asia Pacific Antifungal Drugs Market
10. Latin America Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Antifungal Drugs Market Size and Forecast by Type
10.3. Latin America Antifungal Drugs Market Size and Forecast by Application
10.4. Latin America Antifungal Drugs Market Size and Forecast by Administration
10.4.1. Brazil Antifungal Drugs Market
10.4.1.1. Growing Incidence of Candidemia Among Hospitalized Patients.
10.4.2. Mexico Antifungal Drugs Market
10.4.2.1. Increasing Antifungal Resistance in the Region.
10.4.3. Rest of Latin America Antifungal Drugs Market
11. MEA Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Antifungal Drugs Market Size and Forecast by Type
11.3. MEA Antifungal Drugs Market Size and Forecast by Application
11.4. MEA Antifungal Drugs Market Size and Forecast by Administration
11.5. South Africa Antifungal Drugs Market
11.5.1.1. Increasing Demand for the Antifungal Drugs in the Region.
11.6. Rest of MEA Antifungal Drugs Market
12. Companies in the Antifungal Drugs Market
12.1. Pfizer, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. GlaxoSmithKline Plc
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. Bayer Healthcare LLC
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Novartis AG
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Sanofi-Aventis
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Merck & Co.,
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Glenmark Pharmaceuticals Ltd.
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. Basilea Pharmaceutica Ltd.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. SCYNEXIS Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. F2G Ltd
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Antifungal Drugs Market Drivers & Restraints 2021
Table 7. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 41. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 42. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 43. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 44. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 45. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 46. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 47. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 48. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 54. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 59. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 60. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 61. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 62. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 63. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 64. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 69. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 73. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 74. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 75. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 76. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 77. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 78. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 79. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 80. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 81. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 82. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 83. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 84. North America Antifungal Drugs Market Forecast By Administration 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 85. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 86. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table87. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 88. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 89. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 90 North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 91. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 92. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 93. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 94. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 95. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 96. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 97. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 99. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 102. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 104. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 109. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 114. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 119. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 123. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 124. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 125. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 126. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 127. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 129. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 133. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 134. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 135. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario U)
Table 136. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %), (COVID - Scenario W)
Table 137. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 138. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 142. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 158. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 169. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 170. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 171. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 172. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 173. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 174. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 175. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 176. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 177. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 178. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 179. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 180. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 181. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 182. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 183. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 184. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 185. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 186. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 187. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 188. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 189. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 190. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 191. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 192. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 193. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 194. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 195. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 196. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 197. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 198. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 199. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 200. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 201. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 202. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 203. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 204. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 205. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 206. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 207. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 208. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 209. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 210 Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 211. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 212. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 213. Leading 10 Antifungal Drugs Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 214. Pfizer Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 215. Pfizer Inc. Antifungal Drugs Selected Recent Contracts 2020 (Date, Program Type, Details)
Table 216. Pfizer Inc. Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 217. GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, Website)
Table 218. GlaxoSmithKline Plc Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 219. Bayer Healthcare LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 220. Bayer Healthcare LLC Antifungal Drugs Selected Recent Contracts 2017-2020 (Date, Program Type, Details)
Table 221. Bayer Healthcare LLC Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 222. Novartis AG Profile 2020 (CEO, HQ, Founded, Website)
Table 223. Novartis AG Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 224. Novartis AG Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 225. Sanofi-Aventis Profile 2020 (CEO, HQ, Founded, Website)
Table 226 Sanofi-Aventis Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 227. Merck & Co. Profile 2020 (CEO, HQ, Founded, Website)
Table 228. Merck & Co Antifungal Drugs Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 229. Merck & Co Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 230. Glenmark Pharmaceuticals Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 231. Glenmark Pharmaceuticals Ltd Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 232. Basilea Pharmaceutical Ltd. Profile 2020 (CEO, HQ, Founded, Website)
Table 233. Basilea Pharmaceutical Ltd. Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 234. Scynexis Inc Profile 2020 (CEO, HQ, Founded, Website)
Table 235. Scynexis Inc Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 236. Scynexis Inc Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 237. F2G Ltd Total Company Sales 2015-2020 (US$M, AGR %)
Table 238. F2G Ltd Product Offering (Segment, Product Offerings)
Table 239. Other Companies Involved in the Antifungal Drugs Market (Company, Location)
LIST OF FIGURES
Figure 1. Antifungal Drugs Market Overview
Figure 2. Antifungal Drugs Market By Type Overview
Figure 3. Antifungal Drugs Market By Application Overview
Figure 4. Antifungal Drugs Market By Administration Overview
Figure 5 Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 16. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 17. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 18. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 19. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 20. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (Before COVID)
Figure 26. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 27. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 28. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 29. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 30. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 31. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 32. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 33. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 34. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 35. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (Before COVID)
Figure 36. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 37. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 38. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 39. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 40. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (Before COVID)
Figure 41. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 42. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 43. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 44. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 45. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 51. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 56. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 61. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 62. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 63. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 64. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 65. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (Before COVID)
Figure 66. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 67. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 68. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 69. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 70. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (Before COVID)
Figure 71. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 72. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 73. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 74. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 75. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 76. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 77. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 78. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 79. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 80. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 81. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 82. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 83. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 84. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 85. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 86. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 87. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 88. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 89. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 90. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 91. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 92. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 93. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 94. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 95. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 98. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100 Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (Before COVID)
Figure 101. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 102. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 103. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 104. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 105. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 106. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 107. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 108. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 109. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 110. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 111. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 112. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 113. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 114. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 115. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 117. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 118. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 119. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 120. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 121. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123 China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 126. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 127. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 128. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 129. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 130. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 132. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 133. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 134. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 135. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 136. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 141. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 146. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 147 Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 149. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 150. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M)
Figure 151. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 156. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 157. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 158. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 159. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 160. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 161. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 162. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 166. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M)
Figure 171. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 172. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 173. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 174. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 175. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 176. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 177. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 178. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 179. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 180. Porter’s Five Force Analysis
Companies Mentioned
1. Pfizer Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
15. Endo Pharmaceuticals Solution Inc.
16. Astellas Pharma, Inc.
17. Sigma-Aldrich Corporation
18. Agilent Technologies, Inc.
19. Beckman Coulter, Inc.
20. Bausch Health Companies Inc.
21. Tecan Group.
22. Sun Pharmaceutical Industries Ltd.
23. Macleods Pharmaceuticals Pvt. Ltd.
24. Mankind Pharmaceuticals Ltd.
25. MSD Pharmaceuticals Private Ltd.
26. Hegde & Hegde Pharmaceuticals LLP
27. East India Pharmaceutical Works
28. Zydus Cadila
29. Creative Biolabs
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Antifungal Drugs Market
2.1. Antifungal Drugs Market Definition
2.2. By Type Submarkets Definitions
2.3. By Application Submarkets Definitions
2.4. By Administration Submarkets Definitions
3. Antifungal Drugs Market Overview
3.1. Global Antifungal Drugs Market Size and Forecast by Region
3.2. Global Antifungal Drugs Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Incidences of Fungal Infection.
3.3.1.2. Increasing Awareness to Treat Infection Among People.
3.3.1.3. Invasive Procedures at Hospitals Increases Risk of Fungal Infections.
3.3.2. Market Restraints/Challenges
3.3.2.1. Emerging Antifungal Resistance in Drugs.
3.3.2.2. Availability of Limited Number of Antifungal Drugs to Treat Fungal Infection.
3.3.3. Opportunities
3.3.3.1. Ongoing R&D for Developing Advanced Antifungal Drugs
3.3.3.2. Increasing Demand for Antifungal Drugs as Over the Counter (OTC) Drugs.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Antifungal Drugs Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Azoles
4.1.2. Echinocandins
4.1.3. Polyenes
5. Global Antifungal Drugs Market Analysis and Forecast, 2021-2031 By Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Aspergillosis
5.1.2. Rising Patients with the Weak Immune System or Lung Disease
5.1.3. Dermatophytosis
5.1.4. Dermatophytosis is an Infection of Skin, Hair, Or Nails Caused by Dermatophyte.
5.1.5. Candidiasis
5.1.6. Candida Albicans is the Most Common Fungal Infection, Which Normally Lives on the Skin and Inside the Body.
5.1.7. Others
6. Global Antifungal Drugs Market Analysis and Forecast, 2021-2031 By Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Drugs
6.1.2. Powders
6.1.3. Others
7. North America Antifungal Drugs Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Antifungal Drugs Market Size and Forecast by Type
7.3. North America Antifungal Drugs Market Size and Forecast by Application
7.4. North America Antifungal Drugs Market Size and Forecast by Administration
7.5. U.S. Antifungal Drugs Market
7.5.1. Increasing Cases of Candidemia
7.6. Canada Antifungal Drugs Market
7.6.1. Increasing Awareness for Fungal Infection
8. Europe Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Antifungal Drugs Market Size and Forecast by Type
8.3. Europe Antifungal Drugs Market Size and Forecast by Application
8.4. Europe Antifungal Drugs Market Size and Forecast by Administration
8.5. UK Antifungal Drugs Market
8.6. Germany Antifungal Drugs Market
8.7. France Antifungal Drugs Market
8.8. Rest of Europe Antifungal Drugs Market
9. Asia Pacific Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Antifungal Drugs Market Size and Forecast by Type
9.3. Asia Pacific Antifungal Drugs Market Size and Forecast by Application
9.4. Asia Pacific Antifungal Drugs Market Size and Forecast by Administration
9.5. China Antifungal Drugs Market
9.5.1. Increasing Prevalence of Fungal Infection Among Elderly.
9.6. India Antifungal Drugs Market
9.6.1. Increasing Number of Fungal Infections in the Region.
9.7. Japan Antifungal Drugs Market
9.7.1. Growing Use of Antifungals Such as Echinocandin
9.8. Rest of Asia Pacific Antifungal Drugs Market
10. Latin America Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Antifungal Drugs Market Size and Forecast by Type
10.3. Latin America Antifungal Drugs Market Size and Forecast by Application
10.4. Latin America Antifungal Drugs Market Size and Forecast by Administration
10.4.1. Brazil Antifungal Drugs Market
10.4.1.1. Growing Incidence of Candidemia Among Hospitalized Patients.
10.4.2. Mexico Antifungal Drugs Market
10.4.2.1. Increasing Antifungal Resistance in the Region.
10.4.3. Rest of Latin America Antifungal Drugs Market
11. MEA Antifungal Drugs Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Antifungal Drugs Market Size and Forecast by Type
11.3. MEA Antifungal Drugs Market Size and Forecast by Application
11.4. MEA Antifungal Drugs Market Size and Forecast by Administration
11.5. South Africa Antifungal Drugs Market
11.5.1.1. Increasing Demand for the Antifungal Drugs in the Region.
11.6. Rest of MEA Antifungal Drugs Market
12. Companies in the Antifungal Drugs Market
12.1. Pfizer, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. GlaxoSmithKline Plc
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. Bayer Healthcare LLC
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Novartis AG
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Sanofi-Aventis
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Merck & Co.,
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Glenmark Pharmaceuticals Ltd.
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. Basilea Pharmaceutica Ltd.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. SCYNEXIS Inc.
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. F2G Ltd
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Antifungal Drugs Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Antifungal Drugs Market Drivers & Restraints 2021
Table 7. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Azoles Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Echinocandins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Polyenes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Aspergillosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 41. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 42. Dermatophytosis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 43. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 44. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 45. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 46. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 47. Candidiasis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 48. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 49. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 50. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 51. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 52. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 53. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 54. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 55. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 56. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 57. Antifungal Drugs Market Forecast By Administration 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 58. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 59. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 60. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 61. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 62. Drugs anticoagulant Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 63. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 64. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 65. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 66. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 67. Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 68. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 69. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 70. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 71. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 72. Regional Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 73. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 74. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 75. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 76. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 77. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 78. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 79. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 80. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 81. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 82. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 83. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 84. North America Antifungal Drugs Market Forecast By Administration 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 85. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 86. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table87. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 88. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 89. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 90 North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 91. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 92. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 93. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 94. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 95. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 96. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 97. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 98. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 99. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 100. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 101. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 102. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 103. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 104. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 109. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 110. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 111. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 112. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 113. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 114. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 115. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 116. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 117. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 118. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 119. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 120. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 121. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 122. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 123. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 124. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 125. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 126. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 127. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 128. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 129. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 130. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 131. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 132. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 133. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 134. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 135. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario U)
Table 136. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %CAGR %), (COVID - Scenario W)
Table 137. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 138. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 139. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 140. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 141. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 142. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 143. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 144. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 145. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 146. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 147. Asia Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 148. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 149. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 150. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 151. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 152. Asia Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 153. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 154. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 155. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 156. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 157. Asia Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 158. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 159. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 160. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 161. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 162. Asia Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 163. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 164. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 165. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 166. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 167. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 168. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 169. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 170. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 171. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 172. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 173. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 174. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 175. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 176. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 177. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 178. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 179. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 180. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 181. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 182. RoAPAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 183. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 184. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 185. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 186. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 187. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 188. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 189. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 190. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 191. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 192. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 193. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 194. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 195. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 196. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 197. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 198. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 199. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 200. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 201. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 202. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 203. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 204. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 205. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 206. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 207. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 208. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 209. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 210 Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 211. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 212. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 213. Leading 10 Antifungal Drugs Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 214. Pfizer Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 215. Pfizer Inc. Antifungal Drugs Selected Recent Contracts 2020 (Date, Program Type, Details)
Table 216. Pfizer Inc. Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 217. GlaxoSmithKline Plc Profile 2020 (CEO, HQ, Founded, Website)
Table 218. GlaxoSmithKline Plc Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 219. Bayer Healthcare LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 220. Bayer Healthcare LLC Antifungal Drugs Selected Recent Contracts 2017-2020 (Date, Program Type, Details)
Table 221. Bayer Healthcare LLC Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 222. Novartis AG Profile 2020 (CEO, HQ, Founded, Website)
Table 223. Novartis AG Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 224. Novartis AG Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 225. Sanofi-Aventis Profile 2020 (CEO, HQ, Founded, Website)
Table 226 Sanofi-Aventis Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 227. Merck & Co. Profile 2020 (CEO, HQ, Founded, Website)
Table 228. Merck & Co Antifungal Drugs Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 229. Merck & Co Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 230. Glenmark Pharmaceuticals Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 231. Glenmark Pharmaceuticals Ltd Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 232. Basilea Pharmaceutical Ltd. Profile 2020 (CEO, HQ, Founded, Website)
Table 233. Basilea Pharmaceutical Ltd. Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 234. Scynexis Inc Profile 2020 (CEO, HQ, Founded, Website)
Table 235. Scynexis Inc Antifungal Drugs Product Offering (Segment, Product Offerings)
Table 236. Scynexis Inc Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 237. F2G Ltd Total Company Sales 2015-2020 (US$M, AGR %)
Table 238. F2G Ltd Product Offering (Segment, Product Offerings)
Table 239. Other Companies Involved in the Antifungal Drugs Market (Company, Location)
LIST OF FIGURES
Figure 1. Antifungal Drugs Market Overview
Figure 2. Antifungal Drugs Market By Type Overview
Figure 3. Antifungal Drugs Market By Application Overview
Figure 4. Antifungal Drugs Market By Administration Overview
Figure 5 Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 16. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 17. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 18. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 19. Antifungal Drugs Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 20. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Antifungal Drugs Submarket Forecast By Administration 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (Before COVID)
Figure 26. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 27. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 28. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 29. Regional Antifungal Drugs Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 30. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 31. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 32. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 33. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 34. North America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 35. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (Before COVID)
Figure 36. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 37. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 38. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 39. North America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 40. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (Before COVID)
Figure 41. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 42. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 43. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 44. North America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 45. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 51. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. US Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 56. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. Canada Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 61. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 62. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 63. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 64. Europe Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 65. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (Before COVID)
Figure 66. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 67. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 68. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 69. Europe Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 70. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (Before COVID)
Figure 71. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 72. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 73. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 74. Europe Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 75. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 76. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 77. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 78. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 79. Europe Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 80. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 81. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 82. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 83. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 84. UK Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 85. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 86. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 87. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 88. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 89. Germany Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 90. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 91. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 92. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 93. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 94. France Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 95. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 98. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. Rest of Europe Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100 Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (Before COVID)
Figure 101. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 102. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 103. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 104. Asia-Pacific Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 105. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 106. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 107. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 108. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 109. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 110. Asia-Pacific Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 111. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 112. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 113. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 114. Asia-Pacific Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 115. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 117. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 118. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 119. Asia-Pacific Antifungal Drugs Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 120. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 121. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123 China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. China Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 126. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 127. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 128. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 129. India Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 130. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 132. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 133. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 134. Japan Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 135. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 136. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. Rest of APAC Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 141. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Middle East Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 146. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 147 Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 149. Middle East Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 150. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M)
Figure 151. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Middle East Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 156. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 157. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 158. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 159. Rest of Middle East Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 160. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M)
Figure 161. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 162. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Latin America Antifungal Drugs Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M)
Figure 166. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Latin America Antifungal Drugs Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M)
Figure 171. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario V)
Figure 172. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario U)
Figure 173. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario W)
Figure 174. Latin America Antifungal Drugs Market Forecast By Administration 2021-2031 (US$M) (COVID - Scenario L)
Figure 175. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %)
Figure 176. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 177. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 178. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 179. Rest of Latin America Antifungal Drugs Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 180. Porter’s Five Force Analysis
Companies Mentioned
1. Pfizer Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
15. Endo Pharmaceuticals Solution Inc.
16. Astellas Pharma, Inc.
17. Sigma-Aldrich Corporation
18. Agilent Technologies, Inc.
19. Beckman Coulter, Inc.
20. Bausch Health Companies Inc.
21. Tecan Group.
22. Sun Pharmaceutical Industries Ltd.
23. Macleods Pharmaceuticals Pvt. Ltd.
24. Mankind Pharmaceuticals Ltd.
25. MSD Pharmaceuticals Private Ltd.
26. Hegde & Hegde Pharmaceuticals LLP
27. East India Pharmaceutical Works
28. Zydus Cadila
29. Creative Biolabs
Companies Profiled in the Report
1. Pfizer, Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
List of Companies Mentioned in the Report:
1. Pfizer Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
15. Endo Pharmaceuticals Solution Inc.
16. Astellas Pharma, Inc.
17. Sigma-Aldrich Corporation
18. Agilent Technologies, Inc.
19. Beckman Coulter, Inc.
20. Bausch Health Companies Inc.
21. Tecan Group.
22. Sun Pharmaceutical Industries Ltd.
23. Macleods Pharmaceuticals Pvt Ltd.
24. Mankind Pharmaceuticals Ltd.
25. MSD Pharmaceuticals Private Ltd.
26. Hegde &Hegde Pharmaceuticals LLP
27. East India Pharmaceutical Works
28. Zydus Cadila
29. Creative Biolabs
List of Organizations Mentioned in the Report
1. World Health Organization
2. The European Medicines Agency (EMA)
3. The American Association for Cancer Research.
4. Organic Process Research & Development
5. The Leading International Fungal Education (LIFE)
6. Department of Biology
7. US Food & Drug Administration
8. US National Library of Medicine
9. National Institutes of Health
10. National Association for Biomedical Research
11. Center for Disease Control and Prevention CDC
12. DermNet NZ
13. The Medical Journal of Australia
14. Imperial Fungal Diseases Group
15. Department of Infectious Diseases and Immunity
16. Institute of Infectious Disease and Molecular Medicine
17. Journal of the American college of Cardiology
18. National Association of Orthopaedic Nurses
19. National Foundation for Infectious Diseases.
20. Clinical Infectious Diseases
21. Center for Diseases Dynamics, Economics & Policy (CDDEP)
22. The Global Health Security Agenda (GHSA)
1. Pfizer, Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
List of Companies Mentioned in the Report:
1. Pfizer Inc.
2. GlaxoSmithKline Plc
3. Bayer Healthcare LLC
4. Novartis AG
5. Sanofi-Aventis
6. Merck & Co.,
7. Glenmark Pharmaceuticals Ltd.
8. Basilea Pharmaceutica Ltd.
9. SCYNEXIS Inc.
10. F2G Ltd
11. Cipla Health
12. Kramer Laboratories,
13. Enzon Pharmaceuticals
14. Gilead Science Inc.
15. Endo Pharmaceuticals Solution Inc.
16. Astellas Pharma, Inc.
17. Sigma-Aldrich Corporation
18. Agilent Technologies, Inc.
19. Beckman Coulter, Inc.
20. Bausch Health Companies Inc.
21. Tecan Group.
22. Sun Pharmaceutical Industries Ltd.
23. Macleods Pharmaceuticals Pvt Ltd.
24. Mankind Pharmaceuticals Ltd.
25. MSD Pharmaceuticals Private Ltd.
26. Hegde &Hegde Pharmaceuticals LLP
27. East India Pharmaceutical Works
28. Zydus Cadila
29. Creative Biolabs
List of Organizations Mentioned in the Report
1. World Health Organization
2. The European Medicines Agency (EMA)
3. The American Association for Cancer Research.
4. Organic Process Research & Development
5. The Leading International Fungal Education (LIFE)
6. Department of Biology
7. US Food & Drug Administration
8. US National Library of Medicine
9. National Institutes of Health
10. National Association for Biomedical Research
11. Center for Disease Control and Prevention CDC
12. DermNet NZ
13. The Medical Journal of Australia
14. Imperial Fungal Diseases Group
15. Department of Infectious Diseases and Immunity
16. Institute of Infectious Disease and Molecular Medicine
17. Journal of the American college of Cardiology
18. National Association of Orthopaedic Nurses
19. National Foundation for Infectious Diseases.
20. Clinical Infectious Diseases
21. Center for Diseases Dynamics, Economics & Policy (CDDEP)
22. The Global Health Security Agenda (GHSA)
Download sample pages
Complete the form below to download your free sample pages for Antifungal Drug Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Antifungal Drug Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
13 September 2023
